USA flag logo/image

An Official Website of the United States Government

Reduction of Cerebral Edema using Ventricular Therapies

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
66715
Program Year/Program:
2003 / SBIR
Agency Tracking Number:
NS043832
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
TWIN STAR MEDICAL
1000 Westgate Drive St Paul, MN 55114-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2003
Title: Reduction of Cerebral Edema using Ventricular Therapies
Agency: HHS
Contract: 1R43NS043832-01A1
Award Amount: $184,461.00
 

Abstract:

DESCRIPTION (provided by applicant): Cerebral edema after traumatic brain injury and severe stroke is a life-threatening condition that is refractory to conventional treatments in a significant population of patients. Current treatments (i.e. hyperventilation, osmotic diuretic(s) or hypothermia) are associated with serious side effects that increase with prolonged use. Intracranial hypertension is caused by elevated tissue water content, primarily due to hyperosmosis of ischemic tissue. Thus, removal of water may be an effective treatment. The research plan details feasibility tests of a novel, safe, and effective method of removing water that can be placed within a standard ventriculostomy catheter. Pilot studies have shown a 50% reduction in water uptake by brain tissue in an ex vivo model. In vitro studies will be completed to optimize catheter material and design. Further ex vivo tissue studies will be completed, as well as studies of human post-traumatic CSF. Tissue water removal in a scale model of the human cerebroventricular system will be tested. The goal is to reduce edema in tissue samples without an increase in CSF osmolarity. Successful development and marketing of this proprietary methodology could significantly reduce morbidity and mortality after human TBI, stroke, and other neurological disorders associated with cerebral edema. In Phase II, further efficacy testing of catheter systems is planned in experimental models of cerebral edema and human studies.

Principal Investigator:

William V. Fowler

Business Contact:

Jim Stice
7635765172
JAMESSTICE@AOL.COM
Small Business Information at Submission:

TWIN STAR MEDICAL
TWIN STAR MEDICAL 914 S 8TH ST, MC 860C ROSEVILLE, MN 55415

EIN/Tax ID: 411892833
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No